Literature DB >> 19058336

Interaction of methylenetetrahydrofolate reductase C677T, cytochrome P4502E1 polymorphism and environment factors in esophageal cancer in Kazakh population.

Jiang-Mei Qin1, Lei Yang, Bo Chen, Xiu-Mei Wang, Feng Li, Pei-Hua Liao, Lin He.   

Abstract

AIM: To evaluate the association and interaction of genetic polymorphisms in methylenetetrahydrofolate reductase (MTHER) and cytochrome P4502E1 (CYP4502E1), environment risk factors with esophageal cancer (EC) in Kazakh, a high EC incidence area of Xinjiang Uygur Autonomous Region, China.
METHODS: A 1:2 matched case-control study was conducted with 120 cases of EC and 240 population- or hospital-based controls. The controls were matched for sex, nationality, area of residence and age within a 5-year difference. MTHER and CYP4502E1 genotypes were identified by PCR-based restriction fragment length polymorphism (RFLP). A conditional logistic regression model was established to identify risk factors. The strata method was adopted in interaction analysis.
RESULTS: Low consumption of green vegetables and fresh fruits, alcohol drinking, and unsafe water (shallow well, or river) were found to be the risk factors for EC. Individuals with the MTHFR677 (C/T+T/T) genotype had a 2.62-fold (95% CI: 1.61-4.28) risk of developing EC compared with those who carried the C/C genotype. Individuals with the CYP4502E1C1/C1 genotype had a 3.00-fold (95% CI: 1.82-4.96) risk compared with those who carried the CYP4502E1 (C1/C2+C2/C2) genotype. Gene-environment interaction analysis showed that MTHFR677 gene polymorphism was correlated with consumption of green vegetables and fresh fruit, while CYP4502E1 C1/C1 was correlated with alcohol drinking and unsafe drinking water. MTHFR and CYP4502E1 analysis of gene-gene interaction showed that individuals with the MTHFR677 (C/T+T/T) and CYP4502E1C1/C1 genotypes had a 7.41-fold (95% CI: 3.60-15.25) risk of developing EC compared with those who carried the MTHFR677C/C and CYP4502E1 RsaI C1/C2+C2/C2 genes, and the interaction rate was higher than that of the two factors alone.
CONCLUSION: Low consumption of green vegetables and fresh fruits, alcohol drinking, and unsafe water (shallow well, or river) and polymorphisms in MTHFR and CYP4502E1 genes are important risk factors for EC. There is a synergistic interaction among polymorphisms in MTHFR and CYP4502E1 genes and environment factors. MTHFR and CYP4502E1 genes can be used as biomarkers for prevention of EC in Kazakh, Xinjiang Uygur Autonomous Region, China.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19058336      PMCID: PMC2773864          DOI: 10.3748/wjg.14.6986

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  31 in total

Review 1.  N-nitrosodiethanolamine.

Authors: 
Journal:  IARC Monogr Eval Carcinog Risks Hum       Date:  2000

Review 2.  Genetic polymorphisms and esophageal cancer risk.

Authors:  Toru Hiyama; Masaharu Yoshihara; Shinji Tanaka; Kazuaki Chayama
Journal:  Int J Cancer       Date:  2007-10-15       Impact factor: 7.396

3.  Interaction between cytochrome P-450 2E1 polymorphisms and environmental factors with risk of esophageal and stomach cancers in Chinese.

Authors:  Changming Gao; Toshiro Takezaki; Jianzhong Wu; Zhongyou Li; Jiandong Wang; Jianhua Ding; Yanting Liu; Xu Hu; Tianliang Xu; Kazuo Tajima; Haruhiko Sugimura
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2002-01       Impact factor: 4.254

4.  Methylenetetrahydrofolate reductase polymorphisms increase risk of esophageal squamous cell carcinoma in a Chinese population.

Authors:  C Song; D Xing; W Tan; Q Wei; D Lin
Journal:  Cancer Res       Date:  2001-04-15       Impact factor: 12.701

5.  Associations between genetic polymorphisms of Phase I and II metabolizing enzymes, p53 and susceptibility to esophageal adenocarcinoma.

Authors:  A G Casson; Z Zheng; D Chiasson; K MacDonald; D C Riddell; J R Guernsey; D L Guernsey; J McLaughlin
Journal:  Cancer Detect Prev       Date:  2003

6.  Segregation analysis of esophageal cancer in a moderately high-incidence area of northern China.

Authors:  W Zhang; J E Bailey-Wilson; W Li; X Wang; C Zhang; X Mao; Z Liu; C Zhou; M Wu
Journal:  Am J Hum Genet       Date:  2000-06-06       Impact factor: 11.025

7.  [A case-control study on the risk factors of esophageal cancer in Linzhou].

Authors:  J Lu; S Lian; X Sun; Z Zhang; D Dai; B Li; L Cheng; J Wei; W Duan
Journal:  Zhonghua Liu Xing Bing Xue Za Zhi       Date:  2000-12

Review 8.  Folate and carcinogenesis: an integrated scheme.

Authors:  S W Choi; J B Mason
Journal:  J Nutr       Date:  2000-02       Impact factor: 4.798

9.  Genetic polymorphisms of p53 and GSTP1,but not NAT2,are associated with susceptibility to squamous-cell carcinoma of the esophagus.

Authors:  J M Lee; Y C Lee; S Y Yang; W L Shi; C J Lee; S P Luh; C J Chen; C Y Hsieh; M T Wu
Journal:  Int J Cancer       Date:  2000-09-20       Impact factor: 7.396

10.  Impact of genetic polymorphisms in cytochrome P450 2E1 and glutathione S-transferases M1, T1, and P1 on susceptibility to esophageal cancer among high-risk individuals in China.

Authors:  W Tan; N Song; G Q Wang; Q Liu; H J Tang; F F Kadlubar; D X Lin
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2000-06       Impact factor: 4.254

View more
  12 in total

1.  Genetic variations in MTHFR and esophageal squamous cell carcinoma susceptibility in Chinese Han population.

Authors:  Weifeng Tang; Sheng Zhang; Hao Qiu; Lixin Wang; Bin Sun; Jun Yin; Haiyong Gu
Journal:  Med Oncol       Date:  2014-04-01       Impact factor: 3.064

2.  CYP1A1 and CYP2E1 genotypes and risk of esophageal squamous cell carcinoma in a high-incidence region, Kashmir.

Authors:  Gulzar Ahmad Bhat; Idrees Ayoub Shah; Muzamil Ashraf Makhdoomi; Beenish Iqbal; Rumaisa Rafiq; Sumaiya Nabi; Akbar Masood; Mohd Maqbool Lone; Nazir Ahmad Dar
Journal:  Tumour Biol       Date:  2014-02-08

3.  CYP2E1 Rsa I/Pst I polymorphism contributes to oral cancer susceptibility: a meta-analysis.

Authors:  Yuming Niu; Yuanyuan Hu; Mingyue Wu; Fei Jiang; Ming Shen; Chunbo Tang; Ning Chen
Journal:  Mol Biol Rep       Date:  2011-05-07       Impact factor: 2.316

4.  CYP2E1 Rsa I/Pst I polymorphism and esophageal cancer risk: a meta-analysis based on 1,088 cases and 2,238 controls.

Authors:  Yuming Niu; Hua Yuan; Weidong Leng; Yongchu Pang; Ning Gu; Ning Chen
Journal:  Med Oncol       Date:  2010-03-02       Impact factor: 3.064

Review 5.  A literature review of MTHFR (C677T and A1298C polymorphisms) and cancer risk.

Authors:  Muzeyyen Izmirli
Journal:  Mol Biol Rep       Date:  2012-10-19       Impact factor: 2.316

6.  Alcohol consumption and corresponding factors: A novel perspective on the risk factors of esophageal cancer.

Authors:  Qiao Peng; Hui Chen; Ji-Rong Huo
Journal:  Oncol Lett       Date:  2016-04-01       Impact factor: 2.967

7.  The methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and tumor risk: evidence from 134 case-control studies.

Authors:  Min Tang; Shang-Qian Wang; Bian-Jiang Liu; Qiang Cao; Bing-Jie Li; Peng-Chao Li; Yong-Fei Li; Chao Qin; Wei Zhang
Journal:  Mol Biol Rep       Date:  2014-04-18       Impact factor: 2.316

Review 8.  Association between alcohol consumption and cancers in the Chinese population--a systematic review and meta-analysis.

Authors:  Ying Li; Huan Yang; Jia Cao
Journal:  PLoS One       Date:  2011-04-15       Impact factor: 3.240

9.  A Genetic Variant in miRNA-219-1 Is Associated with Risk of Esophageal Squamous Cell Carcinoma in Chinese Kazakhs.

Authors:  Xiaoyue Song; Weiyan You; Jianbo Zhu; Xiaobin Cui; Jianming Hu; Yunzhao Chen; Wei Liu; Lianghai Wang; Shugang Li; Yutao Wei; Lan Yang; Feng Li
Journal:  Dis Markers       Date:  2015-08-24       Impact factor: 3.434

10.  Cytochrome P450 2E1 RsaI/PstI polymorphism and risk of esophageal cancer: A meta-analysis of 17 case-control studies.

Authors:  Wei-Dong Leng; Xian-Tao Zeng; Yong-Ji Chen; Xiao-Li Duan; Yu-Ming Niu; Rong-Pei Long; Zhi-Xiao Luo
Journal:  Exp Ther Med       Date:  2012-08-28       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.